Reuters on MSN2h
Blackstone, Bain to bid for Mitsubishi pharma unit in up to $3.5 billion deal, sources say
HONG KONG (Reuters) - Global private equity firms Blackstone and Bain Capital are among final bidders for Mitsubishi Tanabe ...
The Globe and Mail13h
Blackstone and Bain Capital among final bidders for Mitsubishi pharma unit, sources say
Global private equity firms Blackstone and Bain Capital are among final bidders for Mitsubishi Tanabe Pharma, a unit of Japan ...
FierceBiotech8d
Mitsubishi Tanabe inks $480M biobucks pact with Dewpoint for preclinical ALS program
Mitsubishi Tanabe Pharma is offering Dewpoint Therapeutics up to $480 million biobucks in a new research pact centering ...
BioPharma Dive9d
Dewpoint, Mitsubishi partner on ALS drug in deal worth up to $480M
The collaboration is another vote of confidence in Dewpoint’s biomolecular condensates research, which had already attracted ...
Outsourcing-pharma8d
Mitsubishi teams up with Dewpoint in $480m ALS deal
As part of the deal, Dewpoint can expect an undisclosed upfront payment from Mitsubishi Tanabe Pharma Corporation (MTPC) in ...
Dewpoint Therapeutics and Mitsubishi Tanabe Pharma Corporation Enter Research Collaboration to Advance Small Molecule Condensate Modulator for ALS
Both companies will collaborate to advance a small molecule condensate modulator targeting TDP-43, with the potential to ...
GlobalData on MSN7d
Dewpoint Therapeutics and Mitsubishi Tanabe link on ALS treatment
Dewpoint Therapeutics CEO Ameet Nathwani stated: “This partnership underscores the transformative potential of our small ...
Business Insider1d
Dewpoint Therapeutics and ConcertAI Announce the First Phase of their Translational Oncology Partnership
Through collaborations with Bayer, Novo Nordisk, Evotec, and Mitsubishi Tanabe Pharma Corporation, Dewpoint pushes the boundaries to accelerate the translation of condensate biology into medicine for ...
The Victoria Advocate9d
Mitsubishi Tanabe Pharma America to Present Data on Investigational ND0612 at the 2024 Annual Meeting of the Parkinson Study Group
JERSEY CITY, N.J., Dec. 4, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of two abstracts on investigational ND0612 in Parkinson's disease (PD ...
Blackstone, Bain to bid for Mitsubishi pharma unit in up to $3.5 bln deal, sources say
HONG KONG, Dec 13 (Reuters) - Global private equity firms Blackstone and Bain Capital are among final bidders for Mitsubishi ...
manilatimes9d
Dewpoint Therapeutics and Mitsubishi Tanabe Pharma Corporation Enter Research Collaboration to Advance Small Molecule Condensate Modulator for ALS
Both companies will collaborate to advance a small molecule condensate modulator targeting TDP-43, with the potential to address the underlying pathology of 97% of ALS patients - Mitsubishi Tanabe ...